Fundamental Data for BAX

BAXTER INT(NYSE:BAX)

Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company''s products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors'' offices and by patients, at home, under physician supervision.

# Employees: 48500

Address: One Baxter Parkway,Deerfield,IL,USA

Phone: 847-948-2000

Fax: 847-948-3948

Website: www.baxter.com

Email:

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

Robert L. Parkinson Jr. (Chmn.; C.E.O.)

Robert M. Davis (Corp. V.P.; C.F.O.)

Karenann K. Terrell (Corp. V.P.; Chief Info. Off.)

John J. Greisch (Presi.; Corp. V.P.)

Susan R. Lichtenstein (Corp. V.P.; Gen. Counsl.; Corp. Sec.,)

Dividend

Ex-Dividend Date: 9/8/2009

Annual Dividend: $1.04

Current Dividend Yield: $1.91

Dividend Paid (3 months): $0.26

Indicated Dividend: $0.28

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/21/2010

Mean EPS (Next Qtr): $1.03

Mean EPS (Year): $3.80

Mean Estimate(Long Term): $11.53

P/E Ratio(Based on EPS estimate): 14.300

Number of Estimates: 16

Shares Performance

Period	BAX	Compare to S&P
YTD	1.38 %	-16.09 %
4 Weeks	-1.36 %	-2.43 %
12 Weeks	-4.31 %	-9.79 %

Shares Information

Analyst Coverage: Y

Avg Volume: 4390102

Shares Outstanding: 602M

Market Cap: $32.75B

52 Week High: $60.50

52 Week Low: $46.41

P/E Ratio: 14.760

PEG Ratio: 1.240

Split: On 5/31/2001 BAX split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 2.08 %

EPS Growth in Last Year: 11.36 %

Sales Growth in Last Quarter: 0.70 %

Sales Growth in Last Quarter: -0.19 %

Financials

Qtr Book Value: $4.48

Cash Flow/Share: $12.09

Change in Payout Ratio: -0.010

Price/Sales: 2.680